Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joris R de Groot

Showing results (151-160 of 214) with videos related to

Pageof 22
Sort By:
JACC. Clinical Electrophysiology|March 23, 2019
Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT StudyWouter R Berger, Jolien Neefs, Nicoline W E van den Berg, et al.
Frontiers in Cardiovascular Medicine|March 19, 2025
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillationEva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, et al.
JCI Insight|August 21, 2020
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablationJasmeet S Reyat, Winnie Chua, Victor R Cardoso, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2023
The influence of atrial high-rate episodes on stroke and cardiovascular death: an updateTobias Toennis, Emanuele Bertaglia, Axel Brandes, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Journal of the American College of Cardiology|September 10, 2016
Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT StudyAntoine H G Driessen, Wouter R Berger, Sébastien P J Krul, et al.
Heart Rhythm|March 25, 2020
Cardiac radioablation-A systematic reviewMartijn H van der Ree, Oliver Blanck, Jacqueline Limpens, et al.
Circulation. Arrhythmia and Electrophysiology|November 19, 2011
Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?Zeliha Koyak, Joris R de Groot, Isabelle C Van Gelder, et al.
Pageof 22

Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
JACC. Clinical Electrophysiology|March 23, 2019
Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT StudyWouter R Berger, Jolien Neefs, Nicoline W E van den Berg, et al.
Frontiers in Cardiovascular Medicine|March 19, 2025
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillationEva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, et al.
JCI Insight|August 21, 2020
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablationJasmeet S Reyat, Winnie Chua, Victor R Cardoso, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2023
The influence of atrial high-rate episodes on stroke and cardiovascular death: an updateTobias Toennis, Emanuele Bertaglia, Axel Brandes, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Journal of the American College of Cardiology|September 10, 2016
Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT StudyAntoine H G Driessen, Wouter R Berger, Sébastien P J Krul, et al.
Heart Rhythm|March 25, 2020
Cardiac radioablation-A systematic reviewMartijn H van der Ree, Oliver Blanck, Jacqueline Limpens, et al.
Circulation. Arrhythmia and Electrophysiology|November 19, 2011
Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?Zeliha Koyak, Joris R de Groot, Isabelle C Van Gelder, et al.
Pageof 22